Medicom has officially launched a $50-million mask-filter manufacturing plant development project in the Greater Montreal Area.
The Meltech Innovation plant is being constructed in Saint-Eustache, Que., and will mainly produce the meltblown polyropylene component of surgical and respiratory masks, which filters harmful particles.
“The construction of our new mask-filter plant represents another important milestone in our vertical and sustainable integration strategy,” said Guillaume Laverdure, CEO of Point-Clarie, Que.-based Medicom in a news release.
“Once operational, this critical component that we have mostly imported from Europe up till now will travel only 30 km from Saint-Eustache to be transformed into face and respiratory (N95) masks in Montreal.”
Privately owned Medicom produces infection-control products and operates in more than 50 countries. The federal government has committed to invest up to $29 million in the plant through the Strategic Innovation Fund.
A mask-innovation centre will operate beside the plant. Meltech will also develop products for air filtration, membrane filtration, battery separators, supercapacitors and other uses.
“All of this will be done with a view to marketing and exporting,” said Medicom.
Monte Stewart serves as Content Director - Canada for Connect Commercial Real Estate.
Based in Vancouver, British Columbia, Monte provides daily news coverage of major Canadian commercial real estate markets, including Vancouver, Toronto, Montreal and Calgary. He has written about the real estate sector for various media outlets and Avison Young since the early 2000s.
In addition, he has covered sports, general news and business for several leading wire services and publications, including The Canadian Press, The Associated Press, The Calgary Herald, The Globe and Mail, Research Money, The Daily Oil Bulletin, Natural Gas World and The Toronto Star.
Monte is active in his community as a youth basketball coach and raises funds for such charitable causes as Movember.